This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wadkins, R. M. Articles by Von Hoff, D. D. Search for Related Content PubMed PubMed Citation Articles by Wadkins, R. M. Articles by Von Hoff, D. D.

Water Soluble 20(S)-Glycinate Esters of 10,11-Methylenedioxycamptothecins Are Highly Active against Human Breast Cancer Xenografts¹

Cancer Therapy and Research Center, Institute for Drug Development, San Antonio, Texas 78245 [R. M. W., B. V., J. M., G. M., S. W., D. D. V. H.]; Department of Molecular Pharmacology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105 [P. M. P.]; and Research Triangle Institute, Research Triangle Park, North Carolina 27709 [G. M., M. C. W., M. E. W.]

Water-soluble 20(S)-glycinate esters of two highly potent 10,11-methylenedioxy analogues of camptothecin (CPT) have been synthesized and evaluated for their ability to eradicate human breast cancer tumor xenografts. The glycinate ester moiety increases the water solubility of the 10,11-methylenedioxy analogues 4–16-fold. However, in contrast to CPT-11, a water-soluble CPT analogue that was recently approved for second line treatment of colorectal cancer, the 20(S)-glycinate esters do not require carboxylesterase for conversion to their active forms. The glycinate esters are hydrolyzed to their parent, free 20(S)-hydroxyl active analogues in phosphate buffer (pH 7.5) and in mouse and human plasma. The glycinate esters are also 20–40-fold less potent than CPT-11 in inhibiting human acetylcholinesterase. In vivo, we examined 20(S)-glycinate-10,11-methylenedioxycamptothecin, 20(S)-glycinate-7-chloromethyl-10,11-methylenedioxycamptothecin, and CPT-11. We found that the two 10,11-methylenedioxy analogues had antitumor activity against breast cancer xenografts that was comparable to that of CPT-11. Our results indicate that water-soluble 20(S)-glycinate esters of highly potent CPT analogues provide compounds that maintain biological activity, do not require interactions with carboxylesterases, and do not inhibit human acetylcholinesterase.

This article has been cited by other articles:

				R. M. Wadkins, J. L. Hyatt, C. C. Edwards, L. Tsurkan, M. R. Redinbo, C. E. Wheelock, P. D. Jones, B. D. Hammock, and P. M. Potter Analysis of Mammalian Carboxylesterase Inhibition by Trifluoromethylketone-Containing Compounds Mol. Pharmacol., March 1, 2007; 71(3): 713 - 723. [Abstract] [Full Text] [PDF]